A patient’s refusal of an AI scribe has led to a cancelled doctor’s visit, with a regulator backing clinical discretion over patient consent.

Alternative protein innovator V2food has penned new deals as research projects a growing global market for meat substitutes.

Inside Lovisa’s low-cost, high-efficiency model that’s quietly delivering 14x returns and global dominance in the fast jewellery game.

Barker Street Ventures has launched with support from UNSW, giving sophisticated investors access to deep tech spinouts.